EQL Pharma AB (publ) (STO:EQL)
49.00
-1.30 (-2.58%)
At close: Apr 28, 2026
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 1.45 billion as of April 28, 2026. Its market cap has decreased by -28.77% in one year.
Market Cap
1.45B
Enterprise Value
1.81B
Revenue
425.75M
Ranking
n/a
PE Ratio
50.02
Stock Price
49.00
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 1.45B, an increase of 1,749.79%. That is a compound annual growth rate of 26.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.89B |
| Dicot Pharma AB | 765.56M |
| Orexo AB | 705.42M |
| Enzymatica AB | 679.66M |
| Nanexa AB | 609.79M |
| Moberg Pharma AB | 581.87M |
| Cinclus Pharma Holding AB | 563.11M |
| Klaria Pharma Holding AB (publ.) | 225.07M |